This April 28, 2009 photo shows Novavax, a Rockville, Maryland, company that in 2005 turned its attention to flu vaccines. (Photo credit: PAUL J.
RICHARDS/AFP via Getty Images) CANBERRA, Australia (AP) - A U.S. biotechnology company began injecting a coronavirus vaccine candidate into people in Australia on Tuesday with hopes of releasing a proven vaccine this year.
Novavax will inject 131 volunteers in the first phase of the trial testing the safety of the vaccine and looking for signs of its effectiveness, the company’s research chief Dr.
Gregory Glenn said. RELATED: CoronavirusNOW.com, FOX launches national hub for COVID-19 news and updates About a dozen experimental vaccines against the coronavirus are in early stages of testing or